Cryoprotectants (CPAs) are a series of biomaterials developed to reduce cryoinjuries. To achieve the high efficiency of RBC cryopreservation, suitable CPAs should be added before freezing.

The molecules used in this process, known as “cryoprotectants”, are crucial to enable these treatments. In fact, without cryopreservation, such therapies must be deployed immediately, thus limiting ...